Showing results (1-10 of 145) with videos related to
Sort By:
Pageof 15
Hypertension (Dallas, Tex. : 1979)|August 1, 1993
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilationG J Smits, J M Kitzen, M H Perrone, et al.Journal of Cardiovascular Pharmacology|May 5, 1999
Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardiumM J McVey, G J Smits, B F Cox, et al.Journal of Cardiovascular Pharmacology|January 1, 1997
Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized ratsG J Smits, M H Perrone, B F CoxThe Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarctionG J Smits, M McVey, B F Cox, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Regional hemodynamic effects of purinergic P2 receptor subtype agonists in ratsB F Cox, G J SmitsThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202L A Merkel, L M Rivera, D J Colussi, et al.Pharmacology|October 1, 1995
Cardiovascular and antilipolytic effects of the adenosine agonist GR79236L A Merkel, E D Hawkins, D J Colussi, et al.British Journal of Pharmacology|April 1, 1994
Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1-agonist in the dogB F Cox, B D Greenland, M H Perrone, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channelsL A Merkel, R W Lappe, L M Rivera, et al.Journal of Pharmaceutical Sciences|January 1, 1978
Vasodilator activity of adenosine analogsA Gangjee, H P Hogenkamp, J M KitzenPageof 15